HHGC
STJ

Hunting Hill Global Capital’s St Jude Medical STJ Stock Holding History

Hunting Hill Global Capital’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-271,100
Closed -$21.7M – 16
2016
Q4 		$21.7M Buy
+271,100
New +$21.5M 67.61% 1

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Hunting Hill Global Capital's STJ Position: Q1 2017 in Review

Hunting Hill Global Capital sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 271,100 shares — an estimated $21.7M sold.

Hunting Hill Global Capital first reported a position in STJ in Q4 2016 and held it in 1 quarter. The position peaked at $21.7M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Hunting Hill Global Capital reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Hunting Hill Global Capital sold 271,100 St Jude Medical shares in Q1 2017, an estimated $21.7M.
  • Hunting Hill Global Capital first reported a position in St Jude Medical in Q4 2016 and held it in 1 quarter.
  • Hunting Hill Global Capital's St Jude Medical position peaked at $21.7M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Hunting Hill Global Capital's 13F filing for Q1 2017, filed 10 May 2017.